Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of California-Davis Medical Group, Advanced Lung Disease/Transplant Program
2042
mi
from 43215
Sacramento, CA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of California-Davis Medical Group, Advanced Lung Disease/Transplant Program
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
David Geffen School of Medicine
1980
mi
from 43215
Torrance, CA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Florida
714
mi
from 43215
Gainesville, FL
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Florida
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Florida
971
mi
from 43215
Weston, FL
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Florida
971
mi
from 43215
Weston, FL
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
HeartCare Midwest
350
mi
from 43215
Peoria, IL
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
HeartCare Midwest
350
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Indiana University Hospital
166
mi
from 43215
Carmel, IN
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Indiana University Hospital
166
mi
from 43215
Carmel, IN
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Kentuckiana Pulmonary Associates
188
mi
from 43215
Louisville, KY
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Kentuckiana Pulmonary Associates
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
642
mi
from 43215
Boston, MA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
165
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Beaumont Health
303
mi
from 43215
Troy, MI
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Beaumont Health
303
mi
from 43215
Troy, MI
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Nebraska Medical Center
694
mi
from 43215
Omaha, NE
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Nebraska Medical Center
694
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Newark Beth Israel Medical Center
468
mi
from 43215
Newark, NJ
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Newark Beth Israel Medical Center
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Rochester
354
mi
from 43215
Rochester, NY
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Asheville Cardiology Associates
300
mi
from 43215
Asheville, NC
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Asheville Cardiology Associates
300
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University Hospital
129
mi
from 43215
Cleveland, OH
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University Hospital
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Legacy Research Institute
2026
mi
from 43215
Portland, OR
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Legacy Research Institute
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Perelman Center for Advanced Medicine at the University of Pennsylvania
416
mi
from 43215
Philadelphia, PA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Perelman Center for Advanced Medicine at the University of Pennsylvania
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center - Presbyterian Cardiovascular Institute
165
mi
from 43215
Pittsburgh, PA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center - Presbyterian Cardiovascular Institute
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Sentara Cardiovascular Research Institute
422
mi
from 43215
Norfolk, VA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Sentara Cardiovascular Research Institute
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
344
mi
from 43215
Richmond, VA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Aurora Saint Lukes Medical Center
329
mi
from 43215
Milwaukee, WI
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Aurora Saint Lukes Medical Center
329
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Sanatorio San José
5386
mi
from 43215
Caba,
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Sanatorio San José
5386
mi
from 43215
Caba,
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Medicine Jacksonville- Division of Pulmonary & Critical Medicine
668
mi
from 43215
Jacksonville, FL
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Medicine Jacksonville- Division of Pulmonary & Critical Medicine
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Medicine Jacksonville
670
mi
from 43215
Jacksonville, FL
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Medicine Jacksonville
670
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Augusta University
452
mi
from 43215
Augusta, GA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Augusta University
452
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
Piedmont - Georgia Lung Associates
430
mi
from 43215
Austell, GA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Piedmont - Georgia Lung Associates
430
mi
from 43215
Austell, GA
Click here to add this to my saved trials
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
537
mi
from 43215
New Haven, CT
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated:  12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Click here to add this to my saved trials
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
Status: Enrolling
Updated:  12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
Status: Enrolling
Updated: 12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Phoenix Children's Hospital, Children's Heart Center
1658
mi
from 43215
Phoenix, AZ
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Phoenix Children's Hospital, Children's Heart Center
1658
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences; Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences; Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
University of Southern California ACHD Care Program
1970
mi
from 43215
Los Angeles, CA
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
University of Southern California ACHD Care Program
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Ahmanson / UCLA Adult Congenital Heart Disease Center
1972
mi
from 43215
Los Angeles, CA
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Ahmanson / UCLA Adult Congenital Heart Disease Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Berkeley Cardiovascular Medical Group
2098
mi
from 43215
Oakland, CA
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Berkeley Cardiovascular Medical Group
2098
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Lucile Packard Children's Hospital
2101
mi
from 43215
Palo Alto, CA
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital
2101
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Medical Center
553
mi
from 43215
Hartford, CT
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Medical Center
553
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Yale School of Medicine - Adult Congenital Heart Disease Program
537
mi
from 43215
New Haven, CT
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Yale School of Medicine - Adult Congenital Heart Disease Program
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Children's National Medical Center and Washington Hospital Center
328
mi
from 43215
Washington,
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Children's National Medical Center and Washington Hospital Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated:  12/31/1969
Bay Area Cardiology Assoc., P.A.
831
mi
from 43215
Brandon, FL
Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Bay Area Cardiology Assoc., P.A.
831
mi
from 43215
Brandon, FL
Click here to add this to my saved trials